Stonebridge Capital Management Lowered General Dynamics (GD) Holding By $401,310; Evolent Health, Inc. (EVH) Covered By 4 Bulls

General Dynamics Corporation (NYSE:GD) Logo

Among 4 analysts covering Evolent Health (NYSE:EVH), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health has $1700 highest and $1000 lowest target. $12.25’s average target is 21.29% above currents $10.1 stock price. Evolent Health had 5 analyst reports since November 6, 2019 according to SRatingsIntel. Wells Fargo maintained Evolent Health, Inc. (NYSE:EVH) on Wednesday, January 8 with “Overweight” rating. On Monday, December 2 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”. The firm has “Overweight” rating by Piper Jaffray given on Wednesday, November 6. The firm earned “Overweight” rating on Wednesday, November 27 by Cantor Fitzgerald. See Evolent Health, Inc. (NYSE:EVH) latest ratings:

08/01/2020 Broker: Wells Fargo Rating: Overweight Old Target: $19.0000 New Target: $17.0000 Maintain
29/11/2019 Broker: BidaskScore Rating: Buy Downgrade
02/12/2019 Broker: KeyBanc Capital Markets Rating: Overweight Old Target: $20.0000 New Target: $10.0000 Maintain
27/11/2019 Broker: Cantor Fitzgerald Rating: Overweight Old Target: $16.0000 New Target: $10.0000 Maintain
06/11/2019 Broker: Piper Jaffray Rating: Overweight Old Target: $10.0000 New Target: $12.0000 Maintain

Stonebridge Capital Management Inc decreased General Dynamics Corp (GD) stake by 6.48% reported in 2019Q3 SEC filing. Stonebridge Capital Management Inc sold 2,205 shares as General Dynamics Corp (GD)’s stock declined 2.40%. The Stonebridge Capital Management Inc holds 31,828 shares with $5.82M value, down from 34,033 last quarter. General Dynamics Corp now has $52.54B valuation. The stock increased 0.35% or $0.64 during the last trading session, reaching $181.61. About 1.02M shares traded. General Dynamics Corporation (NYSE:GD) has risen 7.33% since January 16, 2019 and is uptrending. It has outperformed by 7.33% the S&P500. Some Historical GD News: 25/04/2018 – General Dynamics 1Q Operating Margin 13.4%; 28/03/2018 – U.S. defense contractor CACI International withdrew its offer to buy peer CSRA on Wednesday, losing a month-long bidding war to General Dynamics; 09/04/2018 – BAE Systems Wins Additional Mk110 Naval Guns Contract for U.S. Navy LCS; 12/04/2018 – Gulfstream Leads Industry in Cabin Connectivity; 24/04/2018 – Gulfstream To Expand In Savannah; 23/03/2018 – Gulfstream Aerospace Extends Successful Student Program To Dallas-Fort Worth; 18/03/2018 – CNBC Wires: CACI seeks to break up General Dynamics’ acquisition of CSRA; 24/04/2018 – NexOptic Selected to Demonstrate Technology to General Dynamics Mission Systems–Canada; 20/03/2018 – Frank Konkel: #Breaking: CSRA Rebuffs CACI Bid; Sweetens Deal With General Dynamics; 20/03/2018 – General Dynamics Boosts CSRA Offer Price to $41.25/Share From $40.75

The stock decreased 4.81% or $0.51 during the last trading session, reaching $10.1. About 1.89M shares traded or 3.63% up from the average. Evolent Health, Inc. (NYSE:EVH) has declined 62.84% since January 16, 2019 and is downtrending. It has underperformed by 62.84% the S&P500. Some Historical EVH News: 06/03/2018 – Evolent Health to Participate in Upcoming Investor Conference; 03/05/2018 – Evolent Health to Host Investor and Analyst Day on May 11, 2018; 10/05/2018 – Evolent Forms Golden Cross: Technicals; 09/05/2018 – EVOLENT 1Q ADJ REV $144.4M, EST. $140.8M; 09/05/2018 – Evolent Health Partners with SOMOS IPA to Accelerate Transition to Value-Based Care in New York City Communities; 05/03/2018 UNITEDHEALTH – AS RESULT OF SALE,ADVISORY BOARD CO’S RIGHT TO NOMINATE 2 DIRECTORS TO EVOLENT HEALTH’S BOARD REDUCED TO RIGHT TO NOMINATE 1 DIRECTOR; 09/05/2018 – Evolent Health Sees 2Q Adj Rev $139M-$143M; 09/05/2018 – Evolent Health Sees 2018 Adjusted Rev $565M to $585M; 09/05/2018 – EVOLENT HEALTH INC EVH.N – QTRLY SHR LOSS $0.18; 09/05/2018 – Evolent Health 1Q Rev $139.7M

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States. The company has market cap of $861.70 million. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management. It currently has negative earnings. The companyÂ’s services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.

More notable recent Evolent Health, Inc. (NYSE:EVH) news were published by: Finance.Yahoo.com which released: “Does Evolent Health, Inc. (NYSE:EVH) Have A Volatile Share Price? – Yahoo Finance” on January 15, 2020, also Streetinsider.com with their article: “UPDATE: Evolent Health (EVH) Active, Shares Gain on Headlines Out of Kentucky – StreetInsider.com” published on December 23, 2019, Prnewswire.com published: “Evolent Health to Participate in Upcoming Investor Conference – PRNewswire” on December 17, 2019. More interesting news about Evolent Health, Inc. (NYSE:EVH) were released by: Benzinga.com and their article: “27 Stocks Moving in Wednesday’s Pre-Market Session – Benzinga” published on January 08, 2020 as well as Finance.Yahoo.com‘s news article titled: “The Co-Founder of Evolent Health, Inc. (NYSE:EVH), Frank Williams, Just Bought 5.8% More Shares – Yahoo Finance” with publication date: December 10, 2019.

Since August 9, 2019, it had 1 buying transaction, and 0 selling transactions for $28,549 activity. 159 shares were bought by Burns Mark Lagrand, worth $28,549 on Friday, August 9.

Investors sentiment decreased to 1.08 in Q3 2019. Its down 0.03, from 1.11 in 2019Q2. It fall, as 33 investors sold GD shares while 279 reduced holdings. 100 funds opened positions while 238 raised stakes. 225.56 million shares or 0.13% more from 225.28 million shares in 2019Q2 were reported. Silvercrest Asset Gru Ltd Liability Co invested in 11,055 shares or 0.02% of the stock. Oakworth Capital holds 0.09% or 2,532 shares in its portfolio. Gibraltar stated it has 21,329 shares. Highlander Capital Mgmt Limited Liability Company has 296 shares for 0.03% of their portfolio. Moreover, Wetherby Asset Mgmt Inc has 0.08% invested in General Dynamics Corporation (NYSE:GD). L S Advsr invested in 6,173 shares or 0.16% of the stock. 3,795 are held by Marshall Wace Llp. 40,297 are held by Comerica Bancorporation. Holowesko Ptnrs Ltd, Bahamas-based fund reported 13,800 shares. Moreover, Vident Inv Advisory Ltd Limited Liability Company has 0.03% invested in General Dynamics Corporation (NYSE:GD). Bristol John W And Communication Inc Ny holds 0.01% or 1,600 shares. Pure Advsrs has invested 0.25% in General Dynamics Corporation (NYSE:GD). 43,486 were reported by Pictet Asset. Tarbox Family Office stated it has 0.01% in General Dynamics Corporation (NYSE:GD). Allstate Corp holds 25,322 shares.

Among 4 analysts covering General Dynamics (NYSE:GD), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 50% are positive. General Dynamics has $215 highest and $17200 lowest target. $196.25’s average target is 8.06% above currents $181.61 stock price. General Dynamics had 15 analyst reports since August 14, 2019 according to SRatingsIntel. Morgan Stanley maintained General Dynamics Corporation (NYSE:GD) on Wednesday, August 14 with “Underweight” rating. The firm has “Buy” rating by Cowen & Co given on Monday, October 14. The rating was maintained by Cowen & Co with “Buy” on Wednesday, October 23. The stock has “Underweight” rating by Morgan Stanley on Thursday, October 10. On Tuesday, October 8 the stock rating was maintained by Barclays Capital with “Buy”. The stock has “Neutral” rating by Credit Suisse on Thursday, October 24. The firm has “Underweight” rating by Morgan Stanley given on Thursday, December 12.

Analysts await General Dynamics Corporation (NYSE:GD) to report earnings on January, 29. They expect $3.45 EPS, up 12.38% or $0.38 from last year’s $3.07 per share. GD’s profit will be $998.11 million for 13.16 P/E if the $3.45 EPS becomes a reality. After $3.14 actual EPS reported by General Dynamics Corporation for the previous quarter, Wall Street now forecasts 9.87% EPS growth.

More notable recent General Dynamics Corporation (NYSE:GD) news were published by: Finance.Yahoo.com which released: “Read This Before You Buy General Dynamics Corporation (NYSE:GD) Because Of Its P/E Ratio – Yahoo Finance” on January 04, 2020, also Finance.Yahoo.com with their article: “How Did General Dynamics Corporation (GD) Compare Against Hedge Fund Darlings in 2019? – Yahoo Finance” published on December 25, 2019, Finance.Yahoo.com published: “Why I Added General Dynamics to My Portfolio – Yahoo Finance” on January 08, 2020. More interesting news about General Dynamics Corporation (NYSE:GD) were released by: Bizjournals.com and their article: “General Dynamics, Serco among winners of $5.1B Army contract – Washington Business Journal” published on January 07, 2020 as well as Fool.com‘s news article titled: “3 Top Defense Stocks to Buy in January – The Motley Fool” with publication date: January 06, 2020.

General Dynamics Corporation (NYSE:GD) Institutional Positions Chart